Navigation Links
Researcher, physician and teacher Phil Gold to be inducted into the Canadian Medical Hall of Fame

This release is available in French.

Prof. Heather Munroe-Blum, Principal and Vice-Chancellor of McGill University, and the Hon. Arthur T. Porter, Director General and CEO of the McGill University Health Centre (MUHC), welcome the news that Dr. Phil Gold is to be inducted into The Canadian Medical Hall of Fame. In 1965, Dr. Gold co-discovered the carcinoembryonic antigen (CEA), the first clinically useful human tumour marker that revolutionized the diagnosis and management of cancer. At a ceremony in April 2010, Dr. Gold and five other distinguished inductees will join the ranks of the existing 76 laureates who have pushed the boundaries of knowledge to improve human health.

"When we talk about our institution's role in transforming health care, we often mention such luminaries as Dr. Wilder Penfield, Sir William Osler and Dr. Maude Abbott who have helped put the MUHC on the world map," noted the Hon. Arthur T. Porter. "These pioneers' contributions to medicine will always be emblematic of our rich heritage but today I wish to underscore another facet of their impact, namely how they and all those who have followed in their footsteps inspire new generations to pursue excellence. Dr. Gold is one of these remarkable individuals. I am honoured to call him both a colleague and a friend."

Dr. Gold was born in Montreal and has remained faithful to his native city for most of his life. A brilliant mind with a distinguished record of scientific achievement in immunology and cancer, Dr. Gold is Professor of Medicine, Physiology and Oncology in the Faculty of Medicine at McGill and Executive Director of the Clinical Research Centre at the Montreal General Hospital, which is part of the Research Institute of the MUHC. He is known to many as a down-to-earth, caring physician, an inspirational leader and a gifted teacherthe latter being clearly of great importance to him: "I am very honoured to be included among the pantheon of great physicians in the Medical Hall of Fame," said Dr. Gold. "Many of them were my teachers and colleagues; from my perspective, the most important thing I've ever done is teach."

Dr. Gold's passion for teaching resonates with Prof. Munroe-Blum: "This has been a great year for McGill. We're very proud that faculty members, scholars and alumni have earned two Nobel Prizes, three Killam Prizes and two Steacie Memorial Fellowships. These awards and Dr. Gold's distinction as the latest inductee in The Canadian Medical Hall of Fame speak volumes to the quality of our professoriate and our commitment to attracting the best from Canada and around the world to support graduate students and the excellence of our programs."

In 1965, Dr. Gold and his colleague, Dr. Samuel Freedman, published a seminal paper on their concept-shifting discovery of CEA, the tumour marker that is found in 70% of cancer patients. This marker was developed into a blood test that remains the most frequently used test in oncology around the world today, in addition to being the standard against which other human tumour markers are measured. Through this work, Dr. Gold is credited for developing the field of Human Tumour Marker Biology. His subsequent demonstration that CEA was in embryonic and fetal tissue initiated the field of oncodevelopmental biology.

The impact of the CEA discovery, along with other work in the division of clinical immunology and allergy at the Montreal General Hospital, led to the establishment of the McGill Cancer Centre in 1974. Thirty-five years later, Dr. Gold's original dream of creating a first-rate cancer centre by centralizing the efforts of McGill University and its affiliated hospitals has been realized through the Research Institute of the MUHC and the Goodman Cancer Centre at McGill.

"The relevance of Dr. Gold's discovery over four decades ago stands today as an indelible testament to the value of research," added Dr. Vassilios Papadopoulos, Director of the Research Institute (RI) and Associate Director General of Research at the MUHC. "He is a trusted friend to his colleagues, an invaluable contributor to many RI committees and a role model for young investigators. I am thrilled that we have thirty-five Cancer Axis investigators at the Research Institute to further Dr. Gold's dream. With our new Comprehensive Cancer Centre and the Centre for Innovative Medicine at the Glen Campus, we will be even better positioned to push the boundaries of new knowledge."

Dr. Gold has received numerous international awards and been elected to many prestigious scientific organizations. He was made a Companion of the Order of Canada (1986), an Officer of the Ordre national du Qubec (1990), and a member of the Academy of Great Montrealers (1986). He received the Gairdner Foundation International Award (with Dr. Freedman, 1978) and the F.N.G. Starr Award from the Canadian Medical Association (1986).

Dr. Gold's fellow Canadian Medical Hall of Fame inductees include Dr. Alan C. Burton MBE, Dr. William A. Cochrane OC, Dr. James C. Hogg OC, Dr. Vera Peters OC and Dr. Calvin R. Stiller CM O. Ont. More than 500 of Canada's leading citizens will come together to celebrate the formal induction of the incoming laureates on April 13, 2010 in Calgary. Eighteen of the current seventy-six laureates have ties to McGill and/or the MUHC.


Contact: Julie Robert
McGill University Health Centre

Related medicine news :

1. Researcher, magnet lab receive $2 million grant to target tuberculosis
2. Dr. Nancy Minshew, Autism Researcher, to Speak at Regional Learning Alliance in Cranberry Township
3. K-State Researcher, Collaborators Study Virulence of Pandemic H1N1 Virus; Work at K-State Would Protect Pig Industry If the Virus Jumps to Swine Populations
4. UMass Boston Researcher, Partner Develop Non-Invasive Technique for Lead Testing in Humans
5. Increased distance to physician associated with thicker skin cancer at diagnosis
6. Broad-based group of physicians calls for improvement in stroke treatment
7. Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up
8. Psychiatrists are the least religious of all physicians
9. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
10. One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
11. Texas Largest Physician Carrier Announces 5th Successive Rate Cut on Anniversary of Lawsuit Reform
Post Your Comments:
(Date:10/13/2015)... ... 13, 2015 , ... T-System and Centegra Health System, a ... department visits per year, today announced the successful and rapid deployment of EV™, ... and financial outcomes. , In less than four days, Centegra Hospitals ...
(Date:10/13/2015)... ... ... Tempe Dental Care, a leading Tempe dentists’ office, celebrates offering gentle, pain free sedation ... than 5 years. A leading cause of emergency room visits, school absences, and missed ... , Sedation dentistry provides an anxiety-free dental experience with safe and ...
(Date:10/13/2015)... , ... October 13, 2015 , ... World Patent ... Snow Blanket, a snow melting invention that helps people in clearing snow away from ... will continue to grow at 3.8% per year," says Scott Cooper, CEO and Creative ...
(Date:10/13/2015)... ... October 13, 2015 , ... According to an ESPN ... orbital fracture when a teammate accidentally elbowed him in the left eye during the ... injury is just one of a series of setbacks, including a knee injury that ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... Saye as the newest professional to introduce the latest development, ThermiVa® temperature controlled ... as a leading professional in Obstetrics and Gynecology and a pioneer in the ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... 13, 2015  Synapse Biomedical Inc. ( ) ... (PAS) studying the use of the NeuRx ® ... enroll patients. the United States ... market-approved criteria. The PAS study group met their initial ... study has since expanded the enrollment target to 150 ...
(Date:10/13/2015)... 2015  SeraCare Life Sciences, a leading partner to ... company,s precision medicine business unit has launched its second ... next-generation sequencing (NGS)-based tumor profiling assays.  The Seraseq TM ... mixture of mutations in key oncogenes and tumor suppressor ... , but is offered at five additional allele frequencies. ...
(Date:10/13/2015)... , Oct. 13 2015 ... the addition of the "US & ... 16 Countries (2010-2021)" report to their ... announced the addition of the "US ... - 16 Countries (2010-2021)" report to ...
Breaking Medicine Technology: